Heemers HV - Search Results

1

Lipid degradation promotes prostate cancer cell survival.

Itkonen HM, Brown M, Urbanucci A, Tredwell G, Ho Lau C, Barfeld S, Hart C, Guldvik IJ, Takhar M, Heemers HV, Erho N, Bloch K, Davicioni E, Derua R, Waelkens E, Mohler JL, Clarke N, Swinnen JV, Keun HC, Rekvig OP, Mills IG. Itkonen HM, et al. Among authors: heemers hv. Oncotarget. 2017 Jun 13;8(24):38264-38275. doi: 10.18632/oncotarget.16123. Oncotarget. 2017. PMID: 28415728 Free PMC article.

2

Progestins and androgens increase expression of Spot 14 in T47-D breast tumor cells.

Heemers H, Vanderhoydonc F, Heyns W, Verhoeven G, Swinnen JV. Heemers H, et al. Biochem Biophys Res Commun. 2000 Mar 5;269(1):209-12. doi: 10.1006/bbrc.2000.2262. Biochem Biophys Res Commun. 2000. PMID: 10694501

3

Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway.

Swinnen JV, Heemers H, Deboel L, Foufelle F, Heyns W, Verhoeven G. Swinnen JV, et al. Oncogene. 2000 Oct 26;19(45):5173-81. doi: 10.1038/sj.onc.1203889. Oncogene. 2000. PMID: 11064454

4

Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway.

Heemers H, Maes B, Foufelle F, Heyns W, Verhoeven G, Swinnen JV. Heemers H, et al. Mol Endocrinol. 2001 Oct;15(10):1817-28. doi: 10.1210/mend.15.10.0703. Mol Endocrinol. 2001. PMID: 11579213

5

Androgen action in the prostate gland.

Yadav N, Heemers HV. Yadav N, et al. Among authors: heemers hv. Minerva Urol Nefrol. 2012 Mar;64(1):35-49. Minerva Urol Nefrol. 2012. PMID: 22402316 Review.

6

RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.

Schmidt LJ, Duncan K, Yadav N, Regan KM, Verone AR, Lohse CM, Pop EA, Attwood K, Wilding G, Mohler JL, Sebo TJ, Tindall DJ, Heemers HV. Schmidt LJ, et al. Among authors: heemers hv. Mol Endocrinol. 2012 May;26(5):716-35. doi: 10.1210/me.2011-1130. Epub 2012 Mar 28. Mol Endocrinol. 2012. PMID: 22456196 Free PMC article.

7

The association between calcium channel blocker use and prostate cancer outcome.

Poch MA, Mehedint D, Green DJ, Payne-Ondracek R, Fontham ET, Bensen JT, Attwood K, Wilding GE, Guru KA, Underwood W, Mohler JL, Heemers HV. Poch MA, et al. Among authors: heemers hv. Prostate. 2013 Jun;73(8):865-72. doi: 10.1002/pros.22632. Epub 2012 Dec 31. Prostate. 2013. PMID: 23280547 Free PMC article.

8

Androgen-responsive serum response factor target genes regulate prostate cancer cell migration.

Verone AR, Duncan K, Godoy A, Yadav N, Bakin A, Koochekpour S, Jin JP, Heemers HV. Verone AR, et al. Among authors: heemers hv. Carcinogenesis. 2013 Aug;34(8):1737-46. doi: 10.1093/carcin/bgt126. Epub 2013 Apr 10. Carcinogenesis. 2013. PMID: 23576568 Free PMC article.

9

Alternative approaches to prevent androgen action in prostate cancer: are we there yet?

Elbanna M, Heemers HV. Elbanna M, et al. Among authors: heemers hv. Discov Med. 2014 May;17(95):267-74. Discov Med. 2014. PMID: 24882718 Free article.

10

Targeting androgen receptor action for prostate cancer treatment: does the post-receptor level provide novel opportunities?

Heemers HV. Heemers HV. Int J Biol Sci. 2014 Jun 1;10(6):576-87. doi: 10.7150/ijbs.8479. eCollection 2014. Int J Biol Sci. 2014. PMID: 24948870 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page